Peer Review History

Original SubmissionNovember 15, 2023
Decision Letter - Dong Wook Chang, Editor
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

PONE-D-23-36641Hospital segregation, critical care strain, and inpatient mortality during the COVID-19 pandemic in New York CityPLOS ONE

Dear Dr. Tsao,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================Thank you for submitting this interesting manuscript.  We have provided reviewer critiques (I have acted as an academic reviewer for this manuscript with critiques provided below) which would help the readership of the journal interpret and understand this interesting data.  Please clarify whether there was an a priori hypothesis and the analysis plan.  Although relative differences in mortality from baseline is a reasonable way to present the data, it would be helpful to see absolute differences in mortality rates (without changes from the baselines) across the hospital quartiles and show whether there are major differences. 

==============================

Please submit your revised manuscript by Feb 16 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Dong Wook Chang

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

3. We notice that your supplementary tables are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

Additional Editor Comments:

Academic Editor Review:

Thank you for submitting this interesting manuscript to PLOS One. I would like to raise the following critiques for your consideration.

This in an interesting manuscript that examines whether hospitals in NYC that serve a higher proportion of Medicaid and uninsured patients experienced greater strain and hospital mortality during the 1st wave of the COVID pandemic. Not surprisingly, the authors found that greater ICU strain was associated with higher mortality. They also present data to show that hospitals that serve more under-served patients (divided by quartiles) had higher mortality rates. Although the findings are interesting, there are several critiques which should be addressed:

Major issues:

1) Based on the description of the statistical analysis plan, it is not clear whether this is a descriptive analysis or whether there was an a priori hypothesis about the mortality across hospital quartiles. This needs to be specified. If there was a pre-specified hypothesis, the appropriate use of statistical tests that examine trends across the quartiles should be used and described.

2) For mortality (both ICU and non-ICU), the authors present relative changes compared to baseline (prior to pandemic). While this provides some interesting information, one can argue that the best outcome to see if there were truly differences in mortality across the hospital quartiles would be risk-adjusted mortality rates (not changes from baseline). These should also be reported in absolute values (i.e. mortality rate) rather than changes from baseline. COVID pneumonia was novel, so it is not clear that changes from a baseline (in which there was no COVID pneumonia) is as relevant as absolute mortality. When one looks at mortality trends during Wave 1 (Supplemental Table 2, Overall in-hospital deaths) across the hospital quartiles, it is not clear that there is an important trend or difference. The authors need to provide some clarity on these trends.

3) The figures are very difficult to read (resolution) so it was challenging to understand the results. The supplementary tables are helpful, but there is an overwhelming amount of data. The authors should improve the clarity and quality of the figures (more informative figure legends would also be helpful) or provide tables that show key results in a way that readers could easily interpret.

Minor Issues:

1) Please provide a brief justification for why Wave 1 was used and not the entire duration of the COVID pandemic (or include additional waves)

2) In the statistical analysis section (page 7, lines 152-153), the authors state that “Possible changes in the composition of admissions between the two periods were also examined.” Please clarify what was examined and how.

3) Please provide some more details on how patient acuity and severity of illness are captured in the database (Page 7, lines 161-162)

4) It might be more appropriate to discuss how this work fits into the existing body of literature rather than offering recommendations to reduce care segregation (Discussion, Page 10-11). The paragraph on how this data might inform preparedness and response in future pandemics is excellent.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The current study describes an important and robust analysis of hospitalization and mortality trends in NYC hospitals during the height of the COVID-pandemic. This analysis is innovative and clearly portrays disparities in hospital burden and negative outcomes associated with safety net hospitals that serve the majority of poor and un or under insured patients. I commend the authors on this thoughtful and important study. I only have some minor suggestions for some clarifications as follows:

1. It may be helpful to explicitly introduce the H+H system in NYC, which is the primary public and safety-net hospital in NYC. This may not be typical of other cities or well-known to non NYC readers, even though many of the highest risk hospitals in the study were part of the system.

2. It is not immediately clear how to interpret patients with "self-pay" - in these data, would this be indicative of being uninsured or under-insured? Technically some very wealthy patients may "self-pay" as well, so would be helpful to explain to the reader how to interpret this and why authors decided to group this type of payment with Medicaid when creating the quartiles.

3. Authors note in the methods "Several alternative proxies for hospital strain were used to assess sensitivity of regression estimates to hospital strain measures" while the results are included in supplementary tables, it would be helpful if authors explicitly listed what was tested.

4. In the results, it would be helpful to start with the total number of hospitals that were examined and how many were distributed across quartiles, to get a sense of spread and volume of hospitals.

5. Authors say "patients of color" when describing some of the results, but they never indicate what race/ethnicity groups they are included in this definition.

6. On line 206 authors say most regression estimates were consistent with previous studies - what previous studies is this referring to? Please reference appropriately

7. All the figures are blurry and I am not able to see or read the labels - please produce higher quality images

8. The figures and tables hold an overwhelming amount of information - I may suggest presenting findings only by non-ICU and ICU and remove the third "all hospitalization" categories, to reduce the amount of information being presented and interpreted.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

The Response to Reviewers is attached as a document.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Dong Wook Chang, Editor

Hospital segregation, critical care strain, and inpatient mortality during the COVID-19 pandemic in New York City

PONE-D-23-36641R1

Dear Dr. Tsao,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at http://www.editorialmanager.com/pone/ and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Dong Wook Chang

Academic Editor

PLOS ONE

Additional Editor/Reviewer Comments (optional):

The authors have addressed reviewers' critiques sufficiently. The revisions have significantly strengthened the quality of the manuscript.

Formally Accepted
Acceptance Letter - Dong Wook Chang, Editor

PONE-D-23-36641R1

PLOS ONE

Dear Dr. Tsao,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Dong Wook Chang

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .